Contact the Editorial Desk

Editorial correspondence

Highlander Peptide welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference that has become out of date, a peer-reviewed study on Epitalon or NAD+ that belongs in the references list and isn't there. Corrections that improve the accuracy of the digest are the most useful messages we receive, and they are read carefully.

The most actionable correspondence specifies three things: the page in question, the precise passage at issue, and a supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the primary source quickly. We welcome notes about independent replications or recently published trials that update the evidence picture; that is exactly the kind of information this desk is built to track.

Editorial mailbox: editors@highlanderpeptide.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, a clear account of what this site does not do. Highlander Peptide is a literature digest, not a clinic, compounding pharmacy, or vendor, so we cannot:

• Advise on, recommend, or comment on human use of Epitalon, NAD+, or any other compound.
• Suggest a dose, schedule, cycle length, or route of administration for any individual.
• Diagnose a condition or assess whether a particular research finding applies to a specific person's health situation.
• Sell, source, recommend, or help locate any compound, supplement, or IV-therapy service from any supplier.
• Respond to requests about stacking, combining, or timing multiple compounds.
• Provide protocol advice for athletes, biohackers, or any other group.

Readers seeking medical guidance on any condition referenced in the underlying research should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and are monitored intermittently.